TAVI and Hypertrophic Cardiomyopathy: An Increasingly Common Association

Stenosis is a common disease affecting 5% of the elderly population. It is associated with hospitalizations, poor quality of life, and mortality. 

angulación aórtica post TAVR

The association between severe aortic stenosis (SAS) and hypertrophic cardiomyopathy (HCM) is increasingly frequent.

Currently, the available information on this scenario is limited and comes mainly from small registries or the analysis conducted by Mhanna et al., who compared transcatheter aortic valve replacement (TAVR) with surgery in this patient group. The results showed that TAVR was associated with lower in-hospital mortality, fewer complications, reduced need for vasoactive drugs, lower incidence of cardiogenic shock, and a shorter hospital stay.

Researchers conducted a meta-analysis including 1095 patients with SAS and HCM. 

Patients with HCM experienced the following:

  • Five times higher mortality rates (odds ratio [OR] 5.79; 95% confidence interval [CI]: 3.38-9.91, p <0.0001; I² = 85%).
  • Four times higher incidence of cardiogenic shock (OR 4.55; 95% CI: 3.40-6.08, p <0.0001; I² = 48%).
  • Higher incidence of vascular complications (OR 2.10; 95% CI: 1.27-3.47, p = 0.004; I² = 14%).
  • Increased renal failure (OR 1.80; 95% CI: 1.36-2.40, p <0.0001; I² = 64%).
  • Greater risk of aortic dissection (OR 4.95; 95% CI: 3.17-7.74, p <0.0001; I² = 0%).

Read also: Mechanical Circulatory Support in Complex Anatomies and Severe Deterioration of Left Ventricular Function.

There were no significant differences in the incidence of atrioventricular (A-V) block, need for permanent pacemaker, or bleeding events.

Conclusion

In patients with severe aortic stenosis and associated hypertrophic cardiomyopathy, TAVR was linked to a higher incidence of mortality, cardiogenic shock, aortic dissection, vascular complications, renal failure, and an increased need for mechanical ventilation compared to those without hypertrophic cardiomyopathy.

Original Title: Transcatheter Aortic Valve Replacement in Hypertrophic Cardiomyopathy: A Systematic Review and Meta‐ Analysis

Reference: Ashraf Ahmed, et al. Catheterization and Cardiovascular Interventions, 2025; 105:754–760 https://doi.org/10.1002/ccd.31367


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Carlos Fava
Dr. Carlos Fava
Member of the Editorial Board of solaci.org

More articles by this author

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...

Cardiac Remodeling After Percutaneous ASD Closure: Should It Be Immediate or Progressive?

Atrial septal defect (ASD) is a common congenital heart disease that generates a left-to-right shunt, leading to right-side chamber overload and a risk of...

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...